PITAVASTATIN
Generic: PITAVASTATIN CALCIUM
Upsher-Smith LaboratoriesManufacturer
ORALRoute
PITAVASTATIN CALCIUMActive Substance
2017-02-03Original Approval
PITAVASTATIN is FDA application ANDA205955, sponsored by SAWAI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class III2025-06-26
Pitavastatin Tablets, 1 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-905Failed Impurity/Degradation Specifications
Class III2025-06-11
Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Failed Impurities/Degradation Specifications.
Class III2026-02-03
Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin ta
Class III2025-06-26
Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906Failed Impurity/Degradation Specifications
Class III2025-06-11
Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma Co., Ltd., 8 Kehu 1st Road, Huwei Chen, Failed Impurities/Degradation Specifications.
Top Reported Reactions
1
MYALGIA
459 reports
2
DIARRHOEA
359 reports
3
DIZZINESS
311 reports
4
NAUSEA
306 reports
5
DYSPNOEA
305 reports
6
DECREASED APPETITE
301 reports
7
HEADACHE
301 reports
8
FATIGUE
300 reports
9
MALAISE
292 reports
10
PRURITUS
290 reports